Johnson Health Tech CoTPE:1736 -0.42%83 EBITDA Margin % is 14.01% as of Dec. 2025, which is 91% above its 10-year median of 7.34. GuruFocus rates TPE:1736 with a GF Score™ of 83/100 and a GF Value™ of NT$155.87 (Modestly Undervalued). The stock has 3 warning signs investors should review. Among 845 Travel & Leisure companies, Johnson Health Tech Co ranks worse than 60.71% on this metric.
Johnson Health Tech Co (TPE:1736) EBITDA Margin % Explanation
EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.
Johnson Health Tech Co EBITDA Margin % Related Terms
Johnson Health Tech Co EBITDA Margin % Historical Data
* Premium members only.
The historical data trend for Johnson Health Tech Co's EBITDA Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
TPE:1736 vs AS, HAS, LTH: EBITDA Margin % Comparison
For the Leisure subindustry, Johnson Health Tech Co's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Johnson Health Tech Co EBITDA Margin % vs Travel & Leisure Industry
For the Travel & Leisure industry and Consumer Cyclical sector, Johnson Health Tech Co's EBITDA Margin % distribution charts can be found below:
* The bar in red indicates where Johnson Health Tech Co's EBITDA Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Johnson Health Tech Co (TPE:1736) has a EBITDA Margin % of 14.01% as of Dec. 2025. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Johnson Health Tech Co and its competitors. This is 91% above median its historical median of 7.34. Over the past decade, Johnson Health Tech Co's EBITDA Margin % has ranged from 3.65 to 11.22. According to the industry distribution chart, Johnson Health Tech Co ranks #513 out of 845 companies in the Travel & Leisure industry, placing it in the top 60.7%.
Is Johnson Health Tech Co's EBITDA Margin % too high?
Johnson Health Tech Co's current EBITDA Margin % of 14.01% is 91% above median its 10-year median of 7.34. Over the past 10 years, this metric has ranged from a low of 3.65 to a high of 11.22. The Travel & Leisure industry median EBITDA Margin % is 15.67. Johnson Health Tech Co's value of 14.01% is 10.6% below this industry median. Based on the distribution chart, Johnson Health Tech Co ranks #513 out of 845 companies in the Travel & Leisure industry, which is below the industry midpoint. Overall, Johnson Health Tech Co has a GF Score™ of 83/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Johnson Health Tech Co's EBITDA Margin % compare to AS and HAS?
According to the Travel & Leisure industry distribution chart, Johnson Health Tech Co ranks #513 out of 845 companies for EBITDA Margin %. This places Johnson Health Tech Co in the lower half of its industry. The industry median EBITDA Margin % is 15.67. Johnson Health Tech Co's value of 14.01% is 10.6% below this benchmark. Historically, Johnson Health Tech Co's own EBITDA Margin % has ranged from 3.65 to 11.22 over the past decade. While the company's 10-year median is 7.34 vs. the industry median of 15.67, Johnson Health Tech Co has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a Travel & Leisure company?
The median EBITDA Margin % among Travel & Leisure companies is 15.67, based on 845 companies in the industry. Companies in the top quartile (top 25%) have a EBITDA Margin % significantly above this median, while those in the bottom quartile fall well below. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Johnson Health Tech Co's current EBITDA Margin % of 14.01% is 10.6% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Johnson Health Tech Co and its competitors. For the Travel & Leisure industry, the median EBITDA Margin % is 15.67 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Johnson Health Tech Co's current EBITDA Margin % is 14.01%, which is 91% above median its own 10-year median of 7.34. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Johnson Health Tech Co stock overvalued right now?
Based on GuruFocus' analysis, Johnson Health Tech Co (TPE:1736) is currently considered Modestly Undervalued. The stock's GF Value™ is NT$155.87, compared to a current price of NT$118.50 — trading 24% below its estimated fair value. The current EBITDA Margin % is 14.01%, which is 91% above median its 10-year median of 7.34 and 10.6% below the Travel & Leisure industry median of 15.67. Johnson Health Tech Co's overall GF Score™ is 83/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For Johnson Health Tech Co (TPE:1736), the current EBITDA Margin % is 14.01% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Johnson Health Tech Co (TPE:1736) Overvalued in 2026?
Based on GuruFocus' analysis, Johnson Health Tech Co stock appears to be undervalued.
The current stock price of NT$118.50 is trading 24% below its estimated GF Value™ of NT$155.87.
GuruFocus considers Johnson Health Tech Co to be Modestly Undervalued.
Key valuation signals for TPE:1736:
EBITDA Margin %: 14.01% (91% above median its 10-year median of 7.34)
GF Value™: NT$155.87 vs. price of NT$118.50 (24% below fair value)
Industry Position: 10.6% below the Travel & Leisure median (#513 of 845)
No single metric tells the full story. See the TPE:1736 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Johnson Health Tech Co Ltd is engaged in the manufacturing and selling of sports equipment, cardio equipment, weight training equipment, and related electronic components. It operates in a single industry segment with four strategic segments: American segment: In charge of selling cardiovascular equipment and research and development of training equipment in America; European segment: In charge of selling cardiovascular equipment in Europe; Asian segment: In charge of manufacturing and selling Fuji massage chairs, cardiovascular equipment and weight training equipment in Asia, and franchising the import and export of the above-mentioned products; and Others: In charge of selling cardiovascular machinery in other areas. Geographically, it operates in the Americas, Europe, Asia, and Other.
83GF Score
Get the complete analysis for TPE:1736
EBITDA Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TPE:1736 has been successfully added to your 
